LR Group
VC Fund
Herzlia B, Israel
LR Group is a VC fund in Herzlia B focused on Printing and Health Care. LR Group has been operating worldwide in the initiation, development, financing, construction, and management of medium and large scale projects in high growth economies. Our experienced teams specialize in Agriculture, Water, Energy & Power, Telecom, Health, and Construction.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries LR Group invests in
Stages LR Group invests in
Countries LR Group invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ami Lustig
|
|||
Roy Ben Yami
|
|||
Zvi Herman
|
|||
Investment Focus
Industry
- Printing 1 (20%)
- Health Care 1 (20%)
- Digital Media 1 (20%)
- Manufacturing 1 (20%)
- Medical Device 1 (20%)
Stage
- Series B 1 (20%)
- Series C 1 (20%)
- Series F 1 (20%)
- Venture - Series Unknown 1 (20%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Ami Lustig
Co-Founder & CEO
|
Co-Founder & CEO | Total investments: 0 | Find email | |
|
Roy Ben Yami
Co -Founder & President
|
Co -Founder & President | Total investments: 0 | Find email | |
|
Zvi Herman
Executive Director
|
Executive Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Scopio Labs
|
Scopio Labs is a provider of Full Field Morphology dedicated to unlocking the potential of imaging and AI in hematology. Uncovering actionable insights from vast amounts of data readily available in the average blood sample and bone marrow aspirate, Scopio's solutions will aim to showcase thousands of cells at scale in high resolution, toenable new hematology diagnostic methods. | $50M / Series C / Feb 09, 2022 | |
|
Scopio Labs
|
Scopio Labs is a provider of Full Field Morphology dedicated to unlocking the potential of imaging and AI in hematology. Uncovering actionable insights from vast amounts of data readily available in the average blood sample and bone marrow aspirate, Scopio's solutions will aim to showcase thousands of cells at scale in high resolution, toenable new hematology diagnostic methods. | $50M / Series C / Feb 09, 2022 | |
Beyeonics
|
Beyeonics Surgical technologies began operating in 2012, led by a team of Elbit Systems senior engineers with a mission to revolutionize the visualization and information presented during surgery. Future products include visualization systems for other surgical applications as well as solutions for spine surgery, minimal invasive procedures,robotic surgery and use in cardiovascular catheterization labs. Operating from Israel, Beyeonics is working in collaboration with Prof. Anat Lowenstein the Head of Ophthalmic Department and Prof. Adiel Barak the Head of the Retina Department in Tel Aviv Sourasky Medical Center and with Dr. Pravin Dugel managing partner at Retinal Consultants of Arizona. | $26M / Venture - Series Unknown / Oct 03, 2021 | |
|
Scopio Labs
|
Scopio Labs is a provider of Full Field Morphology dedicated to unlocking the potential of imaging and AI in hematology. Uncovering actionable insights from vast amounts of data readily available in the average blood sample and bone marrow aspirate, Scopio's solutions will aim to showcase thousands of cells at scale in high resolution, toenable new hematology diagnostic methods. | $16M / Series B / Apr 28, 2020 | |
Highcon
|
Highcon delivers innovation and differentiation that converters, printers, and brand owners all need, transforming “finishing” into a value adding process to positively impact users’ profitability by increasing speed to market, eliminating costly production steps and reducing carbon footprint. The Highcon Euclid is the first fully digital cuttingand creasing machine for converting paper, labels, folding carton and microflute. The Euclid incorporates Highcon’s patented ‘DART’ (Digital Adhesive Rule Technology) to produce creases, and high-speed laser optics to for cutting and etching. Contact info +972-8-9101705 web site: www.highcon.net | $20M / Series F / Jun 28, 2017 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does LR Group invest in?
LR Group invests primarily in Printing, Health Care and Digital Media startups, most often at Series B and Series C stage. Most of the 5 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact LR Group?
Public channels for LR Group include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at LR Group?
The team at LR Group includes Ami Lustig (Co-Founder & CEO), Roy Ben Yami (Co -Founder & President) and Zvi Herman (Executive Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
